Ceva诗华品牌怎么样申请店铺

我要投票

Ceva诗华在兽药行业中的票数：1253 更新时间：2026-02-13

Ceva诗华是哪个国家的品牌？「Ceva诗华」是诗华诺康科技发展(北京)有限公司旗下著名品牌。该品牌发源于北京市，由创始人安东凌(Antonin Bonneau)在2011-11-17期间创立，经过多年的不懈努力和高速发展，现已成为行业的标杆品牌。

外推网助力Ceva诗华品牌出海！将品牌入驻外推网，定制Ceva诗华品牌推广信息，可以显著提高Ceva诗华产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

诗华总部位于法国，自成立以来，公司获得了巨大的成功和发展，已连续5年成为成长较快的世界动物保健品公司。

所有产品均按照GMP规范及全球严格的产品质量标准在欧洲或美国生产，产品范围主要包括畜禽预防用生物制品、抗感染类药、伴侣动物用药及家畜繁殖功能调控药。目前，法国诗华动物保健公司已获中国政府官方注册的禽用疫苗品种涵盖一般肉鸡饲养场所用的全部疫苗。

诗华动物保健公司的前身是赛诺菲安万特集团的一个子公司，即赛诺菲动物营养保健公司。公司的管理层于1999年开始分三次逐步收购，并成立了诗华动物保健公司。在2007年完成的收购中，依托其金融业合作伙伴Euromezzanine，Natixis和 Sagard在2010的鼎力支持，CEVA的管理层及员工获得了在该公司占多数的股权。

在全球6大区域进行运营：西欧，中欧和东欧（包含土耳其），北美，南美，非洲和中东，与亚太区。我们在全球42个国家设有机构，拥有13个研发中心，21个生产基地与3500名员工。我们集研发、生产、市场运营为一体，为宠物，家禽，反刍动物，猪生产药剂产品与疫苗。

Headquartered in France, Shihua has achieved great success and development since its establishment. It has become a world animal health product company with rapid growth for 5 consecutive years. All products are manufactured in Europe or the United States according to GMP specifications and strict global product quality standards. The product range mainly includes biological products for livestock and poultry prevention, anti infective drugs, companion animal drugs and animal reproductive function control drugs. At present, the French Shihua animal health company has been officially registered by the Chinese government with a variety of bird vaccines covering all vaccines used in general broiler breeding sites. Shihua animal health company is formerly a subsidiary of Sanofi Aventis group, namely Sanofi animal nutrition health company. The company's management began to acquire it in three stages in 1999, and established Shihua animal health company. In the acquisition completed in 2007, with the full support of its financial partners, euromezzanine, Natixis and sagard in 2010, CEVA's management and employees obtained a majority stake in the company. Operate in six regions: Western Europe, central and Eastern Europe (including Turkey), North America, South America, Africa and the Middle East, and Asia Pacific. We have institutions in 42 countries, 13 R & D centers, 21 production bases and 3500 employees. We integrate R & D, production and market operation to produce pharmaceutical products and vaccines for pets, poultry, ruminants and pigs.

本文链接： https://brand.waitui.com/9c3485e25.html 联系电话：请联系客服添加联系邮箱：请联系客服添加